Clinical Trial

Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.

Study acronym: RECLAIM
Recruiting
View on ClinicalTrials.gov →
Summary
The RECLAIM study aims to gather a centralized and harmonized dataset, enabling the secondary use of data for building AI-based models that will support diagnosis and prognosis of individual Multiple Sclerosis patient's disease course and treatment response in a real-world setting. Additionally, the data will be used to generate further insights on Multiple Sclerosis progression as well as to develop the tools to monitor this progression.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-19; most recent amendment 2025-12-05.
Status change: Not Yet Recruiting → Recruiting 2025-01-17
Trial Details
NCT Number NCT06280755
Lead Sponsor icometrix
Collaborators: Charite University, Berlin, Germany, Ruhr University of Bochum, Technische Universität Dresden, University Hospital, Lille, Casa di Cura IGEA, General University Hospital, Prague, Hoffmann-La Roche, Bristol-Myers Squibb, Imcyse SA, AB Science, Nocturne UG, Aalto University
Conditions Multiple Sclerosis, NMO Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Radiologically Isolated Syndrome, Clinically Isolated Syndrome
Enrollment 7,000 participants
Start Date 2024-03-01
Primary Completion 2027-04 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2025-12-12